低磁热血是急性损伤的危险因素在患者住院的ST段升高心肌梗塞:一个回顾性观察性研究
Youkai Jin1, Qingcheng Lin2, Dingzhou Wang3
1Department of Cardiology, The People's Hospital of Yuhuan, Taizhou, China.
概括
低血清或低血清是ST段升高心肌梗塞 (STEMI) 患者急性损伤 (AKI) 的重要危险因素. 早期识别和管理低可能有助于减少AKI发病率.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 临床生物化学 临床生物化学
背景情况:
- 急性损伤 (AKI) 是ST段升高心肌梗塞 (STEMI) 患者的常见并发症,与不良的心血管结果相关.
- 低磁血症与不同人群中AKI风险增加有关,但它在STEMI患者中的特定作用需要进一步调查.
研究的目的:
- 检查入院血清水平与住院患有STEMI患者中AKI发生率之间的关联.
主要方法:
- 一项回顾性研究包括1,219名STEMI患者,分为低磁血症 (<0.75毫米/升) 和非低磁血症组.
- 住院期间的AKI发病率是主要结果.
- 使用单变量和多变量逻辑回归分析来评估血清和AKI之间的关系.
主要成果:
- 在1219名患者中,13.4%患有低磁血症,21.0%患有AKI.
- 与非低磁血症组相比,低磁血症组的AKI发病率 (31.9%) 显著高于非低磁血症组 (19.3%;P < .001).
- 多变量分析证实低磁血是AKI的一个独立风险因素 (OR:2.41,95%CI:1.61-3.62;P <.001).
结论:
- 入院低磁血是STEMI患者AKI的独立预测因素.
- 旨在纠正血清度的干预措施可能是减少该患者队列中AKI风险的潜在策略.
更多相关视频
07:03Standardized Colon Ascendens Stent Peritonitis in Rats - a Simple, Feasible Animal Model to Induce Septic Acute Kidney Injury
Published on: February 15, 2022
1.4K
03:13Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
2.1K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
100
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
100
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
448
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
448
01:26Heart Failure Drugs: Inotropic Agents
516
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
516
01:21Skeletal Muscle Relaxants: Adverse Effects
335
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
335
01:22Heart Failure Drugs: Diuretics
339
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
339
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K